We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EXAS market cap is 10B. The company's latest EPS is USD -5.4541 and P/E is -9.73.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 637.52M | 699.26M | 708.66M | 722.62M | 706.79M |
| Operating Income | -102.25M | -18.11M | -18.38M | -33.88M | -89.76M |
| Net Income | -110.23M | -15.81M | -38.24M | -864.59M | -101.22M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.49B | 1.77B | 2.08B | 2.58B | 2.77B |
| Operating Income | -791.68M | -855.68M | -593.51M | -214.39M | -179.24M |
| Net Income | -848.53M | -595.63M | -623.51M | -204.15M | -1.03B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.38B | 6.67B | 6.75B | 5.93B | 5.71B |
| Total Liabilities | 3.24B | 3.48B | 3.54B | 3.53B | 3.31B |
| Total Equity | 3.13B | 3.19B | 3.21B | 2.4B | 2.4B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.93B | 6.68B | 6.23B | 6.47B | 5.93B |
| Total Liabilities | 2.1B | 3.3B | 3.18B | 3.33B | 3.53B |
| Total Equity | 2.82B | 3.39B | 3.04B | 3.15B | 2.4B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -82.31M | 24.75M | 163.47M | 210.54M | 30.81M |
| Investing | -171.44M | -318.57M | -400.28M | -442.16M | -34.44M |
| Financing | -3M | 221.6M | 221.38M | 231.87M | -256.17M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 136.48M | -102.24M | -223.56M | 156.12M | 210.54M |
| Investing | -702.04M | -1.08B | 74.07M | 49.68M | -442.16M |
| Financing | 1.88B | 8.47M | 76.49M | 159.77M | 231.87M |
| Market Cap | 10B |
| Price to Earnings Ratio | -9.73 |
| Price to Sales Ratio | 3.62 |
| Price to Cash Ratio | 16.66 |
| Price to Book Ratio | 4.17 |
| Dividend Yield | - |
| Shares Outstanding | 188.64M |
| Average Volume (1 week) | 2.17M |
| Average Volume (1 Month) | 2.92M |
| 52 Week Change | 19.04% |
| 52 Week High | 72.83 |
| 52 Week Low | 39.97 |
| Spread (Intraday) | 0.04 (0.08%) |
| Company Name | EXACT Sciences Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.exactsciences.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
